Search results
Found 5 matches for
Professor Eileen Parkes appointed to lead Oxford’s Experimental Cancer Medicine Centre
Clinical Trials DNA Damage & Repair Immunology Research Translational Research
17 October 2023
Eileen Parkes, Associate Professor in Innate Tumour Immunology in the Department of Oncology, will lead the expansion of the centre’s programmes in early drug development and biomarker research.
Scientists find genetic ‘marker’ linked to serious side-effects from skin cancer treatment
Department Immunology Research
16 December 2022
New research from the Fairfax Group has identified a genetic marker that could be used to predict a patient’s risk of developing serious side-effects when undergoing immunotherapy treatment for metastatic melanoma.
Department of Oncology to collaborate with Crescendo Biologics
Department Immunology Research
20 September 2019
The Department of Oncology has signed up to collaborate with Crescendo Biologics Ltd (Crescendo), the drug developer of novel, targeted T cell enhancing therapeutics.
Study suggests immune system plays key role in survival after pancreatic cancer surgery
Immunology Research
12 February 2019
Researchers in Oxford have found that an individual’s immune system – and in particular the presence of T-cells amongst tumour cells - may play an important role in survival after surgery to remove pancreatic cancer.